Patents by Inventor Arthur Driscoll

Arthur Driscoll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230118774
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: November 21, 2022
    Publication date: April 20, 2023
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • Patent number: 11622935
    Abstract: The present invention relates to the treatment of ocular diseases in a human subject In particular, the invention relates to an intracameral administration of a sustained release biodegradable intracameral implant.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: April 11, 2023
    Assignee: OCULAR THERAPEUTIX, INC.
    Inventors: Charles D. Blizzard, Ankita Desai, Arthur Driscoll, Michael Goldstein
  • Publication number: 20230040637
    Abstract: Provided herein are sustained-release biodegradable ocular hydrogel implants which are useful in the treatment of certain ocular conditions.
    Type: Application
    Filed: August 3, 2022
    Publication date: February 9, 2023
    Inventors: Peter Jarrett, Rami El-Hayek, Timothy S. Jarrett, Zachary Lattrell, Arthur Driscoll, Charles D. Blizzard
  • Patent number: 11534396
    Abstract: This invention relates to methods of treatment with a sustained release biodegradable ocular implant containing a tyrosine inhibitor dispersed in a hydrogel.
    Type: Grant
    Filed: May 13, 2022
    Date of Patent: December 27, 2022
    Assignee: Ocular Therapeutix, Inc.
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • Publication number: 20220401356
    Abstract: Methods of treating an eye for an ocular condition such as placing a composite depot comprising a xerogel with embedded degradable particles into an anterior chamber of an eye to deliver a therapeutic agent. The xerogel is a hydrogel after exposure to intraocular fluid and is degradable. The degradable particles comprise the therapeutic agent and hydrolytically degrade in the anterior chamber to provide a controlled release of the therapeutic agent into the eye. Materials and processes for making depots are provided as well as alternative methods of their use.
    Type: Application
    Filed: August 18, 2022
    Publication date: December 22, 2022
    Inventors: Amarpreet S. Sawhney, Arthur Driscoll, Charles D. Blizzard, Ankita D. Desai, Peter Jarrett
  • Publication number: 20220347094
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: May 13, 2022
    Publication date: November 3, 2022
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • Patent number: 11439592
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: September 13, 2022
    Assignee: Ocular Therapeutix, Inc.
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • Publication number: 20220218643
    Abstract: The present invention relates to the treatment of ocular diseases in a human subject In particular, the invention relates to an intracameral administration of a sustained release biodegradable intracameral implant.
    Type: Application
    Filed: February 16, 2022
    Publication date: July 14, 2022
    Inventors: Charles D. Blizzard, Ankita Desai, Arthur Driscoll, Michael Goldstein
  • Publication number: 20220079876
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: March 24, 2021
    Publication date: March 17, 2022
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • Publication number: 20210308043
    Abstract: The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
    Type: Application
    Filed: March 24, 2021
    Publication date: October 7, 2021
    Inventors: Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
  • Publication number: 20210251893
    Abstract: The present invention relates to the treatment of ocular diseases in a human subject. In particular, the invention relates to an intracameral administration of a sustained release biodegradable intracameral implant.
    Type: Application
    Filed: February 5, 2021
    Publication date: August 19, 2021
    Inventors: Charles D. Blizzard, Ankita Desai, Arthur Driscoll, Michael Goldstein
  • Publication number: 20210077299
    Abstract: A prosthesis comprising a water-dissolvable coating. A prosthesis for a lacrimal canaliculus comprising a swellable punctal plug with a proximal end and a distal end, with the plug comprising a water-dissolvable biocompatible coating on the distal and/or the proximal end. Materials and methods for making and using the same. A prosthesis for placement in or across natural or prosthetic lumens, ostia, ducts, sinus, or sphincters, the prosthesis comprising a coating. The prosthesis can further provide a depot for sustained drug delivery to tissue.
    Type: Application
    Filed: March 3, 2020
    Publication date: March 18, 2021
    Inventors: Peter Jarrett, Amarpreet S. Sawhney, Michael J. McGrath, Arthur Driscoll, Ankita D. Desai, Michael Bassett
  • Publication number: 20200337990
    Abstract: Provided herein are sustained release biodegradable ocular hydrogel implants which are useful for lowering ocular pressure and for treating related conditions.
    Type: Application
    Filed: April 24, 2020
    Publication date: October 29, 2020
    Inventors: Michael Goldstein, Arthur Driscoll, Charles D. Blizzard, Ankita Desai
  • Publication number: 20200337989
    Abstract: Provided herein are sustained-release biodegradable ocular hydrogel implants which are useful in the treatment of certain ocular conditions.
    Type: Application
    Filed: April 24, 2020
    Publication date: October 29, 2020
    Inventors: Peter Jarrett, Rami El-Hayek, Timothy S. Jarrett, Zachary Lattrell, Arthur Driscoll, Charles D. Blizzard
  • Patent number: 10617563
    Abstract: A prosthesis comprising a water-dissolvable coating. A prosthesis for a lacrimal canaliculus comprising a swellable punctal plug with a proximal end and a distal end, with the plug comprising a water-dissolvable biocompatible coating on the distal and/or the proximal end. Materials and methods for making and using the same. A prosthesis for placement in or across natural or prosthetic lumens, ostia, ducts, sinus, or sphincters, the prosthesis comprising a coating. The prosthesis can further provide a depot for sustained drug delivery to tissue.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: April 14, 2020
    Assignee: Incept, LLC
    Inventors: Peter Jarrett, Amarpreet S. Sawhney, Michael J. McGrath, Arthur Driscoll, Ankita D. Desai, Michael Bassett
  • Publication number: 20180085307
    Abstract: Methods of treating an eye for an ocular condition such as placing a composite depot comprising a xerogel with embedded degradable particles into an anterior chamber of an eye to deliver a therapeutic agent. The xerogel is a hydrogel after exposure to intraocular fluid and is degradable. The degradable particles comprise the therapeutic agent and hydrolytically degrade in the anterior chamber to provide a controlled release of the therapeutic agent into the eye. Materials and processes for making depots are provided as well as alternative methods of their use.
    Type: Application
    Filed: September 25, 2017
    Publication date: March 29, 2018
    Inventors: Amarpreet S. Sawhney, Arthur Driscoll, Charles D. Blizzard, Ankita D. Desai, Peter Jarrett
  • Publication number: 20170020729
    Abstract: A prosthesis comprising a water-dissolvable coating. A prosthesis for a lacrimal canaliculus comprising a swellable punctal plug with a proximal end and a distal end, with the plug comprising a water-dissolvable biocompatible coating on the distal and/or the proximal end. Materials and methods for making and using the same. A prosthesis for placement in or across natural or prosthetic lumens, ostia, ducts, sinus, or sphincters, the prosthesis comprising a coating. The prosthesis can further provide a depot for sustained drug delivery to tissue.
    Type: Application
    Filed: July 22, 2016
    Publication date: January 26, 2017
    Inventors: Peter Jarrett, Amarpreet S. Sawhney, Michael J. McGrath, Arthur Driscoll, Ankitaben P. Desai, Michael Bassett
  • Patent number: 8889889
    Abstract: Crosslinked polymers, methods for their preparation and use, are described in which the crosslinked polymers are formed from at least two polymer precursors, one of which is designed, upon degradation of the crosslinked polymer, to release the second polymer precursor in its original, unmodified chemical form.
    Type: Grant
    Filed: April 15, 2013
    Date of Patent: November 18, 2014
    Assignee: Confluent Surgical, Inc.
    Inventors: Rachit Ohri, Phillip Blaskovich, Joshua Kennedy, Steven L. Bennett, Arthur Driscoll
  • Patent number: 8440309
    Abstract: Crosslinked polymers, methods for their preparation and use, are described in which the crosslinked polymers are formed from at least two polymer precursors, one of which is designed, upon degradation of the crosslinked polymer, to release the second polymer precursor in its original, unmodified chemical form.
    Type: Grant
    Filed: January 31, 2011
    Date of Patent: May 14, 2013
    Assignees: Confluent Surgical, Inc., Covidien LP
    Inventors: Rachit Ohri, Phillip Blaskovich, Joshua Kennedy, Steven L. Bennett, Arthur Driscoll
  • Patent number: 8387899
    Abstract: An applicator assembly for mixing at least a first and second component is provided. The applicator assembly includes a manifold configured for operable engagement with at least a first and second source of component, the manifold including at least a first and second component channel therethrough, an elongated shaft extending distally from the manifold, the elongated shaft including at least a first and second component lumen extending the length thereof, the at least first and second component channels in fluid communication with the at least first and second component channels, a tip assembly defining a first chamber, an intermediate chamber and a final chamber.
    Type: Grant
    Filed: September 28, 2011
    Date of Patent: March 5, 2013
    Assignee: Confluent Surgical, Inc.
    Inventors: Jason Fortier, Les Hull, Arthur Driscoll